These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36930101)

  • 1. Using dashboards to verify coronavirus (COVID-19) vaccinations can reduce fatality rates in countries/regions: Development and usability study.
    Jen TH; Wu JW; Chien TW; Chou W
    Medicine (Baltimore); 2023 Mar; 102(11):e33274. PubMed ID: 36930101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the Kano model to associate the number of confirmed cases of COVID-19 in a population of 100,000 with case fatality rates: An observational study.
    Hsu SY; Chien TW; Yeh YT; Chou W
    Medicine (Baltimore); 2022 Sep; 101(37):e30648. PubMed ID: 36123944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries.
    Duroseau B; Kipshidze N; Limaye RJ
    Front Public Health; 2022; 10():1087138. PubMed ID: 36711400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring income-associated inequalities in COVID-19 vaccination on a global scale: a modeling study.
    Amimo F; Magit A
    J Public Health Policy; 2023 Sep; 44(3):449-463. PubMed ID: 37604927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the absolute advantage coefficient (AAC) to measure the strength of damage hit by COVID-19 in India on a growth-share matrix.
    Yang DH; Chien TW; Yeh YT; Yang TY; Chou W; Lin JK
    Eur J Med Res; 2021 Jun; 26(1):61. PubMed ID: 34167582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccination and governance in the case of low, middle and high-income countries.
    Lupu D; Tiganasu R
    BMC Public Health; 2023 Jun; 23(1):1073. PubMed ID: 37277743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is COVID-19 vaccine inequality undermining the recovery from the COVID-19 pandemic?
    Suárez-Álvarez A; López-Menéndez AJ
    J Glob Health; 2022 May; 12():05020. PubMed ID: 35604879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study.
    Chen Z; Zheng W; Wu Q; Chen X; Peng C; Tian Y; Sun R; Dong J; Wang M; Zhou X; Zhao Z; Zhong G; Yan X; Liu N; Hao F; Zhao S; Zhuang T; Yang J; Azman AS; Yu H
    BMC Med; 2022 Apr; 20(1):130. PubMed ID: 35369871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Country-level and regional COVID-19 burden and determinants across OECD member states and partner countries.
    Ngatu NR; Tayama K; Kanda K; Hirao T
    Environ Health Prev Med; 2022; 27():41. PubMed ID: 36273898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: A global analysis.
    Coccia M
    Environ Res; 2022 Mar; 204(Pt C):112314. PubMed ID: 34736923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worldwide inverse correlation between Bacille Calmette-Guérin (BCG) immunization and COVID-19 mortality.
    Li WX
    Infection; 2021 Jun; 49(3):463-473. PubMed ID: 33495884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of booster vaccination in decreasing COVID-19 age-adjusted case fatality rate: Evidence from 32 countries.
    Zhou C; Wheelock ÅM; Zhang C; Ma J; Dong K; Pan J; Li Z; Liang W; Gao J; Xu L
    Front Public Health; 2023; 11():1150095. PubMed ID: 37143970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Vaccination Coverage and Key Public Health Indicators May Explain Disparities in COVID-19 Country-Specific Case Fatality Rate Within European Economic Area.
    Papadopoulos VP; Emmanouilidou A; Yerou M; Panagaris S; Souleiman C; Varela D; Avramidou P; Melissopoulou E; Pappas C; Iliadou Z; Piperopoulos I; Somadis V; Partsalidis A; Metaxa E; Feresiadis I; Filippou D
    Cureus; 2022 Mar; 14(3):e22989. PubMed ID: 35415037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVAX and equitable access to COVID-19 vaccines.
    Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B
    Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between COVID-19 morbidity, mortality, and gross domestic product, overweight/ obesity, non-communicable diseases, vaccination rate: A cross-sectional study.
    Oshakbayev K; Zhankalova Z; Gazaliyeva M; Mustafin K; Bedelbayeva G; Dukenbayeva B; Otarbayev N; Tordai A
    J Infect Public Health; 2022 Feb; 15(2):255-260. PubMed ID: 35065358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis.
    Castrejon MM; Leal I; de Jesus Pereira Pinto T; Guzmán-Holst A
    Hum Vaccin Immunother; 2022 Nov; 18(6):2102353. PubMed ID: 36084255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Bollyky TJ; Castro E; Aravkin AY; Bhangdia K; Dalos J; Hulland EN; Kiernan S; Lastuka A; McHugh TA; Ostroff SM; Zheng P; Chaudhry HT; Ruggiero E; Turilli I; Adolph C; Amlag JO; Bang-Jensen B; Barber RM; Carter A; Chang C; Cogen RM; Collins JK; Dai X; Dangel WJ; Dapper C; Deen A; Eastus A; Erickson M; Fedosseeva T; Flaxman AD; Fullman N; Giles JR; Guo G; Hay SI; He J; Helak M; Huntley BM; Iannucci VC; Kinzel KE; LeGrand KE; Magistro B; Mokdad AH; Nassereldine H; Ozten Y; Pasovic M; Pigott DM; Reiner RC; Reinke G; Schumacher AE; Serieux E; Spurlock EE; Troeger CE; Vo AT; Vos T; Walcott R; Yazdani S; Murray CJL; Dieleman JL
    Lancet; 2023 Apr; 401(10385):1341-1360. PubMed ID: 36966780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prevalence of COVID-19 in Europe by the End of November 2022: A Cross-Sectional Study.
    Alrasheedi AA
    Cureus; 2023 Jan; 15(1):e33546. PubMed ID: 36779135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.